Program: Bridgehead (Accelerator)
Program targets: scale-ups creating innovative, transformative products or services in the field of health technologies (biotechnology, digital health, medical devices) with a need to internationalise and scale to new markets. Company has to sell a product or services in at least one market in Europe and be ready to open up a new market, and have fewer than 250 full time employees.
Opportunities: Preparation for international expansion and help companies achieve tangible business results in European or Global markets. EIT Health network of incubators, accelerators, and clusters (also referred as Catalysers) is used to achieve the goals. Funding of up to €30,000 for scale-ups aiming at European expansion and €40,000 for SMEs aiming at entering Global markets. Individualised country specific services – local regulations, connections with industry leaders, manufacturers, producers and distributors, testing and etc.
Criteria: Impact of Programme and Clarity of direction, Market Opportunity & Traction, Business Model & Development Strategy, Management Capability, Need to internationalise and expand in Europe, Promising and Credible Scale-up
Activities will take place: June 2021-June 2022 (first intake), November 2021-November 2022 (second intake)
Submission of applications: till 16-03-2021 23:59 CET (first intake) and till 14 September 2021, 23:59h CET (second intake)
More information: https://eithealth.eu/bridgehead/
Laura Fargas email@example.com
Deadline for Applications: 16-03-2021 23:59 CET (first intake), 14 September 2021, 23:59h CET (second intake)